PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways

Human Molecular Genetics

Volumn 10, Issue 3, 2001, Pages 237-242

  Weng, Liang Ping ^a   Brown, Jessica L ^a   Eng, Charis ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CASPASE INHIBITOR; DIMETHYL SULFOXIDE; GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035253607     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.3.237     Document Type: Article

References (46)

1. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
2. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
3. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
4. PTEN and inherited hamartoma-cancer syndromes
5. Genetics of Cowden syndrome: Through the looking glass of oncology
6. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
7. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
8. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome
9. Germline and germline mosaic PTEN mutations associated with a proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis
10. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
11. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
12. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells
13. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
14. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene
15. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death
16. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells
17. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
18. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
19. Apoptosis and the cell cycle
20. Cell cycle regulation and apoptosis
21. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts
22. Mechanisms and consequences of activation of protein kinase B/Akt
23. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
24. Regulation of neuronal survival by the serine-threonine protein kinase Akt
25. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
26. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I
27. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
28. The multiple roles of PTEN in tumor suppression
29. Phosphoinositide kinases
30. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
31. Radiation-induced cell cycle arrest compromised by p21 deficiency
32. Cell cycle and apoptosis: Common pathways to life and death
33. Inhibition of apoptosis by the retinoblastoma gene product
34. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function
35. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
36. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture
37. Serum-free growth of human mammary epithelial cells: Rapid clonal growth in defined medium and extended serial passage with pituitary extract
38. Charcoal-dextran treatment of fetal bovine serum removes an inhibitor of human CFU-megakaryocytes
39. Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis
40. Apoptosis and the cell cycle
41. p53 in signaling checkpoint arrest or apoptosis
42. The role of p53 in cell-cycle control and apoptosis: Implications for cancer
43. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation
44. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
45. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-kinase/AKT in breast cancer cells
46. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast